Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Viale

Showing results (191-200 of 302) with videos related to

Pageof 31
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2010
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancerA DeCensi, A Guerrieri-Gonzaga, S Gandini, et al.
Breast (Edinburgh, Scotland)|January 26, 2013
Additional prognostic value of the 70-gene signature (MammaPrint(®)) among breast cancer patients with 4-9 positive lymph nodesM Saghatchian, S Mook, G Pruneri, et al.
Breast Cancer Research and Treatment|May 27, 2021
Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic reviewD Trapani, F Giugliano, J Uliano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2012
Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trialsJ Huober, S Gelber, A Goldhirsch, et al.
British Journal of Cancer|October 23, 2008
Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activityR Torrisi, V Bagnardi, A Cardillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2014
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter studyM V Dieci, C Criscitiello, A Goubar, et al.
Anticancer Research|March 26, 2002
Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimenL Orlando, M Colleoni, G Curigliano, et al.
Minerva Medica|April 30, 1978
[Acute hepatic failure and renal damage. Experimental and clinical studies]D Galmarini, L Tarenzi, G Cantaluppi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2015
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter studyM V Dieci, C Criscitiello, A Goubar, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 13, 2002
Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspectsC De Cicco, M Pizzamiglio, G Trifirò, et al.
Pageof 31

Showing results (191-200 of 302) with videos related to

Sort By:
Pageof 31
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2010
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancerA DeCensi, A Guerrieri-Gonzaga, S Gandini, et al.
Breast (Edinburgh, Scotland)|January 26, 2013
Additional prognostic value of the 70-gene signature (MammaPrint(®)) among breast cancer patients with 4-9 positive lymph nodesM Saghatchian, S Mook, G Pruneri, et al.
Breast Cancer Research and Treatment|May 27, 2021
Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic reviewD Trapani, F Giugliano, J Uliano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2012
Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trialsJ Huober, S Gelber, A Goldhirsch, et al.
British Journal of Cancer|October 23, 2008
Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activityR Torrisi, V Bagnardi, A Cardillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2014
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter studyM V Dieci, C Criscitiello, A Goubar, et al.
Anticancer Research|March 26, 2002
Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimenL Orlando, M Colleoni, G Curigliano, et al.
Minerva Medica|April 30, 1978
[Acute hepatic failure and renal damage. Experimental and clinical studies]D Galmarini, L Tarenzi, G Cantaluppi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2015
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter studyM V Dieci, C Criscitiello, A Goubar, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 13, 2002
Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspectsC De Cicco, M Pizzamiglio, G Trifirò, et al.
Pageof 31